Search - tctmd.com

Displaying 81 - 100 of 137

Sort: Relevancy | Date

Presentation

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Presenter: G. Tepe

December 15, 2014

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Industry News

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

November 03, 2014

News Daily News

药物洗脱球囊治疗重症下肢缺血患者的膝下病变失败

Todd Neale

October 10, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Industry News

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

September 16, 2014

News Industry News

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

September 16, 2014

Presentation TCT 2014

TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Schulte Karl-Ludwig, MD

September 15, 2014

Presentation TCT 2014

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD

September 15, 2014

News Industry News

NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

September 15, 2014

News Industry News

Teleflex Receives FDA Clearance for 150 cm Length Arrow® GPSCath® Balloon Dilatation Catheters

July 29, 2014

News Industry News

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

July 17, 2014

News Industry News

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

July 14, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Industry News

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

June 04, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

Presentation

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Presenter: Gunnar Tepe

April 14, 2014

Advertisement

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

药物洗脱球囊治疗重症下肢缺血患者的膝下病变失败

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

Teleflex Receives FDA Clearance for 150 cm Length Arrow® GPSCath® Balloon Dilatation Catheters

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content